GT
RPTP

Glenmede Trust’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Glenmede Trust’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-141
Closed -$1K – 2791
2016
Q3 		$1K Buy
+141
New +$1K ﹤0.01% 2554

Glenmede Trust's RPTP Position: Q4 2016 in Review

Glenmede Trust sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 141 shares — an estimated $1K sold.

Glenmede Trust first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $1K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Glenmede Trust reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Glenmede Trust sold 141 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $1K.
  • Glenmede Trust first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • Glenmede Trust's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Glenmede Trust's 13F filing for Q4 2016, filed 14 Feb 2017.